UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 4, 2004
MYRIAD GENETICS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 0-26642 | 87-0494517 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
320 Wakara Way
Salt Lake City, Utah 84108
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (801) 584-3600
(Former name or former address, if changed since last report)
Item 7. Financial Statements and Exhibits.
| (c) | Exhibits. |
| 99.1 | Earnings release dated May 4, 2004 for the three and nine months ended March 31, 2004. |
This earnings release is being furnished pursuant to Item 12 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
Item 12. Results of Operations and Financial Condition
On May 4, 2004, Myriad Genetics, Inc. announced its financial results for the three and nine months ended March 31, 2004. The earnings release is attached hereto as an exhibit to this current report on Form 8-K and is being furnished pursuant to this Item 12 as Exhibit 99.1 to this Current Report on Form 8-K.
Page 2 of 4 pages
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Myriad Genetics, Inc. | ||||
(Registrant) | ||||
Date: May 4, 2004 | By: | /s/ Peter D. Meldrum | ||
Peter D. Meldrum | ||||
President and Chief Executive Officer | ||||
Page 3 of 4 pages
EXHIBIT INDEX
Exhibit Number | Description | |
| 99.1 | Earnings release dated May 4, 2004 for the three and nine months ended March 31, 2004. |
Page 4 of 4 pages